CORCEPT THERAPEUTICS INC Operating Lease, Payments
CORCEPT THERAPEUTICS INC (CORT) reported Operating Lease, Payments of $413.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC operating lease, payments for the quarter ending 2026-06-30 was $413.00K, a 11.32% increase year-over-year.
- CORCEPT THERAPEUTICS INC operating lease, payments for the quarter ending 2026-03-31 was $382.00K, a 54.66% increase year-over-year.
- CORCEPT THERAPEUTICS INC operating lease, payments for the quarter ending 2025-12-31 was $382.00K.
- CORCEPT THERAPEUTICS INC operating lease, payments for the quarter ending 2025-09-30 was $382.00K.
- CORCEPT THERAPEUTICS INC operating lease, payments for fiscal 2025 was $1.38M, a 1.77% increase from fiscal 2024.
- CORCEPT THERAPEUTICS INC operating lease, payments for fiscal 2024 was $1.36M, a 43.20% decline from fiscal 2023.
- CORCEPT THERAPEUTICS INC operating lease, payments for fiscal 2023 was $2.39M, a 5.56% increase from fiscal 2022.
- CORCEPT THERAPEUTICS INC operating lease, payments for fiscal 2022 was $2.27M, a 7.65% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $413.00K 10-Q · filed 2026-07-29 | $795.00K 10-Q · filed 2026-07-29 | $1.18M derived: sum of 3 quarters · filed 2026-07-29 | $1.56M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $382.00K 10-Q · filed 2026-04-30 | $764.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.15M derived: sum of 3 quarters · filed 2026-04-30 | $1.52M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $764.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.14M derived: sum of 3 quarters · filed 2026-07-29 | $1.38M 10-K · filed 2026-02-24 |
| 2025-09-30 | $382.00K 10-Q · filed 2025-11-04 | $753.00K derived: sum of 2 quarters · filed 2026-07-29 | $1.00M 10-Q · filed 2025-11-04 | $1.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $371.00K 10-Q · filed 2026-07-29 | $618.00K 10-Q · filed 2026-07-29 | $618.00K derived: sum of 3 quarters · filed 2026-07-29 | $618.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $247.00K 10-Q · filed 2026-04-30 | $247.00K derived: sum of 2 quarters · filed 2026-04-30 | $247.00K derived: sum of 3 quarters · filed 2026-04-30 | $988.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $741.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.36M 10-K · filed 2026-02-24 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-04 | $741.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.36M 10-Q · filed 2025-11-04 | $1.98M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $741.00K 10-Q · filed 2025-07-31 | $1.36M 10-Q · filed 2025-07-31 | $1.98M derived: sum of 3 quarters · filed 2026-02-24 | $2.59M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $617.00K 10-Q · filed 2025-05-05 | $1.23M derived: sum of 2 quarters · filed 2026-02-24 | $1.85M derived: sum of 3 quarters · filed 2026-02-24 | $2.43M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.23M derived: sum of 2 quarters · filed 2026-02-24 | $1.81M derived: sum of 3 quarters · filed 2026-02-24 | $2.39M 10-K · filed 2026-02-24 |
| 2023-09-30 | $617.00K 10-Q · filed 2024-10-30 | $1.20M derived: sum of 2 quarters · filed 2024-10-30 | $1.77M 10-Q · filed 2024-10-30 | $2.35M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $578.00K 10-Q · filed 2024-07-29 | $1.16M 10-Q · filed 2024-07-29 | $1.73M derived: sum of 3 quarters · filed 2025-02-26 | $2.31M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $578.00K 10-Q · filed 2024-05-01 | $1.16M derived: sum of 2 quarters · filed 2025-02-26 | $1.73M derived: sum of 3 quarters · filed 2025-02-26 | $2.31M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $578.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.16M derived: sum of 2 quarters · filed 2025-02-26 | $1.73M derived: sum of 3 quarters · filed 2025-02-26 | $2.27M 10-K · filed 2025-02-26 |
| 2022-09-30 | $578.00K 10-Q · filed 2023-11-01 | $1.16M derived: sum of 2 quarters · filed 2023-11-01 | $1.69M 10-Q · filed 2023-11-01 | $2.22M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $578.00K 10-Q · filed 2023-08-02 | $1.11M 10-Q · filed 2023-08-02 | $1.64M derived: sum of 3 quarters · filed 2023-08-02 | $2.17M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $530.00K 10-Q · filed 2023-05-03 | $1.06M derived: sum of 2 quarters · filed 2023-05-03 | $1.59M derived: sum of 3 quarters · filed 2023-05-03 | $2.12M derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $530.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.06M derived: sum of 2 quarters · filed 2023-02-28 | $1.59M derived: sum of 3 quarters · filed 2023-02-28 | $2.10M 10-K · filed 2023-02-28 |
| 2021-09-30 | $530.00K 10-Q · filed 2022-11-03 | $1.06M derived: sum of 2 quarters · filed 2022-11-03 | $1.57M 10-Q · filed 2022-11-03 | $2.09M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $530.00K 10-Q · filed 2022-08-04 | $1.04M 10-Q · filed 2022-08-04 | $1.56M derived: sum of 3 quarters · filed 2022-08-04 | $2.07M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $514.00K 10-Q · filed 2022-05-05 | $1.03M derived: sum of 2 quarters · filed 2022-05-05 | $1.54M derived: sum of 3 quarters · filed 2022-05-05 | $1.96M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.03M derived: sum of 2 quarters · filed 2022-02-15 | $1.45M derived: sum of 3 quarters · filed 2022-02-15 | $1.84M 10-K · filed 2022-02-15 |
| 2020-09-30 | $514.00K 10-Q · filed 2020-11-03 | $936.00K derived: sum of 2 quarters · filed 2020-11-03 | $1.33M 10-Q · filed 2020-11-03 | $1.72M derived: sum of 4 quarters · filed 2021-02-23 |
| 2020-06-30 | $422.00K 10-Q · filed 2020-08-04 | $812.00K 10-Q · filed 2020-08-04 | $1.20M derived: sum of 3 quarters · filed 2021-02-23 | $1.59M derived: sum of 4 quarters · filed 2021-02-23 |
| 2020-03-31 | $391.00K 10-Q · filed 2020-05-04 | $782.00K derived: sum of 2 quarters · filed 2021-02-23 | $1.17M derived: sum of 3 quarters · filed 2021-02-23 | $1.56M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-12-31 | $391.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $782.00K derived: sum of 2 quarters · filed 2021-02-23 | $1.17M derived: sum of 3 quarters · filed 2021-02-23 | $1.55M 10-K · filed 2021-02-23 |
| 2019-09-30 | $391.00K 10-Q · filed 2020-11-03 | $782.00K derived: sum of 2 quarters · filed 2020-11-03 | $1.16M 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $391.00K 10-Q · filed 2020-08-04 | $769.00K 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $379.00K 10-Q · filed 2020-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |